Derrick Henry

Running Back

Age: 30
Free Agency: 2026 (UFA)
Accrued Seasons: 8
  • 2024 Salary Cap Charge: $5,105,000 (2.02% of cap)
  • 2024 Cash Payout: $9,000,000 (4.12% of spending)
  • 2024 Cash to Cap Ratio: 1.76
  • Contract Value: $16,000,000 ($8,000,000 APY)
  • Fully Guaranteed Money: $9,000,000
  • Contract Ranking: 8/145 at RB

Current Contract

(UFA, signed 2024)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusRoster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202430$1,210,000$3,895,000$0$1,210,000$5,105,0002.0%
2025 📝
March 15: Roster bonus due
31$6,000,000$3,895,000$1,000,000$0$10,895,0004.2%
Total$7,210,000$7,790,000$1,000,000$1,210,000$16,000,000

Contract Notes

Derrick Henry signed a two year, $16 million contract with the Ravens. $9 million is guaranteed including a $7.79 million signing bonus.

 

Cash Flows

- fully earned money
- unearned or partially earned money
$8M
$16M
20242025
Cash Due$9,000,000$7,000,000
Running Cash$9,000,000$16,000,000
Career Earnings: $64,639,106
Career APY: $8,079,888
Potential Earnings: $72,849,106
Total Guarantees: $48,056,855
Largest Cash Payment: $15,441,176 (2022)
Largest Cap Number: $16,367,647 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
TitansDraftedExpired20164$5,407,930$1,351,983$3,278,855$5,407,930100.0%$1,351,983
TitansFranchiseExpired20204$50,000,000$12,500,000$25,500,000$51,441,176102.9%$12,860,294
RavensUFAActive20242$16,000,000$8,000,000$9,000,000$7,790,00048.7%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Titans8$56,849,106$7,106,138$50,643,2240.0%$4,735,2940.0%
Ravens0$7,790,000$0$00.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2016Titans$450,000$533,260$0$0$0$450,000$983,2600.6%$2,583,040
2017Titans$695,815$533,260$0$0$0$695,815$1,229,0750.6%$695,815
2018Titans$941,630$533,260$0$0$0$0$1,474,8900.7%$941,630
2019Titans$1,187,445$533,260$0$0$0$0$1,720,7050.8%$1,187,445
2020Titans$3,000,000$3,000,000$0$0$0$3,000,000$6,000,0002.7%$15,000,000
2021Titans$10,500,000$3,000,000$0$0$0$10,500,000$13,500,0007.1%$10,500,000
2022Titans$4,000,000$5,367,647$0$1,000,000$0$0$9,367,6474.4%$15,441,176
2023Titans$10,500,000$5,367,647$0$0$500,000$0$16,367,6477.1%$10,500,000
2024Ravens$1,210,000$3,895,000$0$0$0$1,210,000$5,105,0002.0%$9,000,000
2025Ravens$6,000,000$3,895,000$1,000,000$0$0$0$10,895,0004.2%$7,000,000
Total$38,484,890$26,658,334$1,000,000$1,000,000$500,000$15,855,815$66,643,224$72,849,106
Dead Money History
TeamYearCap ChargeCash Paid
Titans2024$4,735,294$0
Total$4,735,294$0

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2016150025.4%0.0%1104904.551313710.5000
2017160040.1%0.0%1486934.7510707.0010
2018160040.9%0.0%21510594.91215996.6011
2019151059.2%0.0%30315405.1161820611.4253
2020160065.7%0.0%37820275.417191146.0000
202180034.7%0.0%2199374.310181548.6000
2022160162.5%0.0%34915384.4133339812.1000
2023170053.1%0.0%28011674.212282147.6000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$9,902,000$8,000,000
Injury Adjusted$9,902,000$8,000,000
test
OTC Valuation $2.7M $5.4M $8M $10.7M $13.4M APY $2.7M $5.3M $8M $10.7M $13.3M $7,072,000 $4,461,285

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.